We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLXY:NASDAQGalaxy Digital Inc. Analysis

Data as of 2026-10-01 - not real-time

$22.74

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Galaxy Digital is neutral at $22.74, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 11.3%. Relative strength is 44.6 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $21.61 and resistance at $27.68.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 78.6% above where the shares trade now. Revenue is contracting at 3.8% on a -0.4% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 82.1%, a beta of 3.84 and a maximum drawdown of 60.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Galaxy Digital Inc. GLXY shares are trading higher on Friday as traders continue to assess the recent second-quarter...Galaxy Digital Inc GLXY reports strong data center progress and strategic partnerships, offsetting a GAAP net loss...Novogratz discusses Helios expansion and digital asset infrastructure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 24.90
  • MACD momentum is negative
  • 30-day price change of +11.3%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 24.90
  • Analyst targets imply +78.6% versus the current price
  • 30-day volatility of 82.1%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -0.4%
  • Analyst targets imply +78.6% versus the current price
  • Negative return on equity of -10.4%

Key Metrics & Analysis

Financial Health

Revenue Growth-3.80%
Profit Margin-0.42%
P/E Ratio-66.7
ROE-10.41%
ROA356.48%
Debt/Equity186.69
P/B Ratio2.4
Op. Cash Flow$-357280000
Free Cash Flow$34.6B
Industry P/E15.1

Technical Analysis

TrendNeutral
RSI44.6
Support$21.61
Resistance$27.68
MA 20$24.54
MA 50$23.06
MA 200$24.90
MACDBearish
VolumeStable
Fear & Greed Index91.82

Valuation

Fair Value$690.85
Target Price$40.63
Upside/Downside78.65%
GradeFair
TypeBlend

Risk Assessment

Beta3.84
Volatility82.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.